Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.3275    0.00 (0.00%)
Bid:
0.325
Ask:
0.33
Spread: 0.005 (1.538%)
Market Cap: £25.46m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Distribution Agreement

21 Jul 2014 07:01

HAYDALE GRAPHENE INDUSTRIES PLC - Distribution Agreement

HAYDALE GRAPHENE INDUSTRIES PLC - Distribution Agreement

PR Newswire

London, July 20

Haydale Graphene Industries plc ("Haydale" or the "Company") Announces Distribution Agreement with Goodfellow Cambridge Limited Haydale Graphene Industries plc (AIM:HAYD), the Company focused on enablingtechnology for the commercialisation of graphene, is pleased to announce it hasentered into a distribution agreement with Goodfellow Cambridge Limited("Goodfellow") ("Agreement"), widely regarded as one of the premier globaldistributors of advanced materials for R&D, prototyping and specialisedmanufacturing. The Agreement is a rolling annual contract and will focus on the globalmarketing and distribution of Haydale HDPlas® functionalised graphenenanoplatelets (GNPs) to major research and industrial clients throughGoodfellow's international network. Ray Gibbs, CEO at Haydale, commented: "This Agreement is integral to the distribution of our functionalised GNPsacross the global R&D market. The research departments served by Goodfellow arethe first step in the adoption of any new material, and this Agreement marks asignificant step forward in demonstrating the improved material properties thatour functionalisation method achieves. The endorsement as a supplier toGoodfellow represents a significant step forward for us, and we are delightedthat they have agreed to list our GNP product." "Goodfellow's extensive customer base will be instrumental in achieving greateraccess and visibility for our HDPlas® range. This will allow more R&D customersworldwide to test the improvement in product performance obtained by addingGNPs functionalised via our plasma process. We look forward to working closelywith them to deliver the HDPlas® range internationally." Stephen Aldersley, Managing Director of Goodfellow, believes that the newrelationship with Haydale is an important expansion of Goodfellow's activitiesin the field of nanoparticles in general and graphene in particular. Commentingon the Agreement, he said: "The Haydale plasma process can demonstrate significant advantages over otherfunctionalisation methods, and we are pleased to be promoting their products toour global customer base in this very important research area. We are alwayslooking for new, unique materials and the Haydale offering is certainly onethat meets our strict criteria." - ends - For further information please contact: Haydale Graphene Industries plc 01269 842 946 John Knowles, Chairman Ray Gibbs, Chief Executive Officer Cairn Financial Advisers LLP (Nomad) 0207 148 7900 Tony Rawlinson Paul Trendell Cantor Fitzgerald Europe (Broker) 020 7894 7000 David Foreman Paul Jewell Hermes Financial PR Trevor Phillips 07889 153 628 Chris Steele 07979 604 687 About Haydale Haydale has developed a patent-pending proprietary scalable plasma process tofunctionalise graphene and other nanomaterials. This enabling technology canprovide Haydale with a rapid and highly cost-efficient method of supplyingtailored solutions to enhance applications for both raw material suppliers andproduct manufacturers. Functionalisation is carried out through a low-pressure plasma process thattreats both mined, organic fine powder and other synthetically producednanomaterial powders, producing high-quality few layered graphenes and graphenenanoplatelets. The process can functionalise with a range of chemical groups,with the level of functionalisation tailored to the customer's needs. Gooddispersion improves the properties and performance of the host material andensures the final product performs as specified. The Haydale plasma process does not use wet chemistry, nor does it damage thematerial being processed; rather, it can clean up any impurities inherent inthe raw material. The technology is a low energy user and most importantlyenvironmentally friendly. The Haydale method is an enabling technology,allowing the Company to work with a raw material producer who seeks to addvalue to the base product and tailor the outputs to meet the targetapplications of the end user. Haydale, based in South Wales and housed in a purpose-built facility forprocessing and handling nanomaterials, is facilitating the application ofgraphenes and other nanomaterials in fields such as inks, sensors, energystorage, photovoltaics, composites, paints and coatings. www.haydale.com About Goodfellow For more than 45 years, the Goodfellow name has been synonymous with smallquantities of high-quality metals, polymers, ceramics and other materials thatmeet the research, development, and specialised production requirements ofscience and industry worldwide. The Goodfellow catalogue contains over 70,000products available for rapid shipment to customers worldwide. Standard productscan be found online at the comprehensive Goodfellow Catalogue(www.goodfellow.com). In addition to the standard products, Goodfellow is ableto offer non-standard products to the customer's specifications as well asmaterials in larger quantities for the production requirements of high-techindustry. The Goodfellow Group of companies consists of Goodfellow CambridgeLimited (UK), Goodfellow Corporation (USA), Goodfellow SARL (France),Goodfellow GmbH (Germany) and Goodfellow Shanghai (China).
Date   Source Headline
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.